Additional file 2 of The lncRNA PARylator promotes PARP1 activation and resistance to DNA‑damaging therapy in esophageal squamous cell carcinoma
Fields of Study & Subjects
PARP inhibition in cancer therapy
Cancer-related molecular mechanisms research
RNA regulation and disease
Publication details
- Journal / source
- Figshare
- Publication date
- 1 January 2026